-+ 0.00%
-+ 0.00%
-+ 0.00%

NEUROGENESIS BIO RECEIVES FDA CLEARANCE TO PROCEED WITH EXPANDED ACCESS PROGRAM FOR NG01 IN PROGRESSIVE MULTIPLE SCLEROSIS

Reuters·11/17/2026 12:00:55

Please log in to view news